Annual Net Income
$4.95 M
-$10.59 M-68.16%
31 December 2023
Summary:
Organogenesis Holdings annual net profit is currently $4.95 million, with the most recent change of -$10.59 million (-68.16%) on 31 December 2023. During the last 3 years, it has fallen by -$12.29 million (-71.31%). ORGO annual net income is now -94.75% below its all-time high of $94.20 million, reached on 31 December 2021.ORGO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$12.33 M
+$29.37 M+172.35%
30 September 2024
Summary:
Organogenesis Holdings quarterly net profit is currently $12.33 million, with the most recent change of +$29.37 million (+172.35%) on 30 September 2024. Over the past year, it has increased by +$9.16 million (+289.36%). ORGO quarterly net income is now -75.82% below its all-time high of $50.99 million, reached on 31 December 2021.ORGO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$7.38 M
+$9.16 M+55.39%
30 September 2024
Summary:
Organogenesis Holdings TTM net profit is currently -$7.38 million, with the most recent change of +$9.16 million (+55.39%) on 30 September 2024. Over the past year, it has dropped by -$20.38 million (-156.77%). ORGO TTM net income is now -107.83% below its all-time high of $94.20 million, reached on 31 December 2021.ORGO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -68.2% | +289.4% | -156.8% |
3 y3 years | -71.3% | -2.0% | -112.0% |
5 y5 years | +107.6% | +214.8% | +83.7% |
ORGO Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -94.8% | at low | -75.8% | +172.3% | -107.8% | +55.4% |
5 y | 5 years | -94.8% | +107.6% | -75.8% | +172.3% | -107.8% | +83.7% |
alltime | all time | -94.8% | +107.6% | -75.8% | +154.8% | -107.8% | +88.6% |
Organogenesis Holdings Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $12.33 M(-172.4%) | -$7.38 M(-55.4%) |
June 2024 | - | -$17.04 M(+711.6%) | -$16.54 M(-384.5%) |
Mar 2024 | - | -$2.10 M(+269.7%) | $5.82 M(+17.6%) |
Dec 2023 | $4.95 M(-68.2%) | -$568.00 K(-117.9%) | $4.95 M(-62.0%) |
Sept 2023 | - | $3.17 M(-40.4%) | $13.00 M(+29.4%) |
June 2023 | - | $5.32 M(-279.1%) | $10.05 M(-25.4%) |
Mar 2023 | - | -$2.97 M(-139.7%) | $13.48 M(-13.2%) |
Dec 2022 | $15.53 M(-83.5%) | $7.49 M(+3381.9%) | $15.53 M(-73.7%) |
Sept 2022 | - | $215.00 K(-97.5%) | $59.04 M(-17.3%) |
June 2022 | - | $8.74 M(-1057.7%) | $71.40 M(-14.3%) |
Mar 2022 | - | -$913.00 K(-101.8%) | $83.35 M(-11.5%) |
Dec 2021 | $94.20 M(+446.6%) | $50.99 M(+305.5%) | $94.20 M(+53.1%) |
Sept 2021 | - | $12.58 M(-39.2%) | $61.52 M(-11.7%) |
June 2021 | - | $20.69 M(+108.1%) | $69.70 M(+59.0%) |
Mar 2021 | - | $9.94 M(-45.7%) | $43.85 M(+149.3%) |
Dec 2020 | $17.23 M | $18.32 M(-11.8%) | $17.59 M(-620.9%) |
Sept 2020 | - | $20.75 M(-501.8%) | -$3.38 M(-90.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2020 | - | -$5.17 M(-68.3%) | -$34.87 M(-11.4%) |
Mar 2020 | - | -$16.31 M(+514.9%) | -$39.36 M(+1.7%) |
Dec 2019 | -$38.71 M(-40.3%) | -$2.65 M(-75.3%) | -$38.71 M(-14.6%) |
Sept 2019 | - | -$10.74 M(+11.3%) | -$45.31 M(-4.9%) |
June 2019 | - | -$9.65 M(-38.4%) | -$47.65 M(-17.9%) |
Mar 2019 | - | -$15.67 M(+69.3%) | -$58.01 M(-10.5%) |
Dec 2018 | -$64.83 M(+672.9%) | -$9.26 M(-29.2%) | -$64.83 M(+3.9%) |
Sept 2018 | - | -$13.08 M(-34.6%) | -$62.37 M(+21.3%) |
June 2018 | - | -$20.01 M(-11.0%) | -$51.41 M(+65.7%) |
Mar 2018 | - | -$22.49 M(+231.1%) | -$31.02 M(+269.8%) |
Dec 2017 | -$8.39 M(-50.6%) | -$6.79 M(+220.8%) | -$8.39 M(-54.8%) |
Sept 2017 | - | -$2.12 M(-656.7%) | -$18.55 M(+12.8%) |
June 2017 | - | $380.30 K(+169.9%) | -$16.45 M(-2.3%) |
Mar 2017 | - | $140.90 K(-100.8%) | -$16.83 M(-0.9%) |
Dec 2016 | -$16.99 M | -$16.96 M(>+9900.0%) | -$16.99 M(>+9900.0%) |
Sept 2016 | - | -$14.50 K(+2800.0%) | -$30.50 K(+90.6%) |
June 2016 | - | -$500.00(-96.8%) | -$16.00 K(+3.2%) |
Mar 2016 | - | -$15.50 K | -$15.50 K |
FAQ
- What is Organogenesis Holdings annual net profit?
- What is the all time high annual net income for Organogenesis Holdings?
- What is Organogenesis Holdings annual net income year-on-year change?
- What is Organogenesis Holdings quarterly net profit?
- What is the all time high quarterly net income for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly net income year-on-year change?
- What is Organogenesis Holdings TTM net profit?
- What is the all time high TTM net income for Organogenesis Holdings?
- What is Organogenesis Holdings TTM net income year-on-year change?
What is Organogenesis Holdings annual net profit?
The current annual net income of ORGO is $4.95 M
What is the all time high annual net income for Organogenesis Holdings?
Organogenesis Holdings all-time high annual net profit is $94.20 M
What is Organogenesis Holdings annual net income year-on-year change?
Over the past year, ORGO annual net profit has changed by -$10.59 M (-68.16%)
What is Organogenesis Holdings quarterly net profit?
The current quarterly net income of ORGO is $12.33 M
What is the all time high quarterly net income for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly net profit is $50.99 M
What is Organogenesis Holdings quarterly net income year-on-year change?
Over the past year, ORGO quarterly net profit has changed by +$9.16 M (+289.36%)
What is Organogenesis Holdings TTM net profit?
The current TTM net income of ORGO is -$7.38 M
What is the all time high TTM net income for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM net profit is $94.20 M
What is Organogenesis Holdings TTM net income year-on-year change?
Over the past year, ORGO TTM net profit has changed by -$20.38 M (-156.77%)